A plant-based biopolymer production platform that combines a cyanobacterial carbon concentrating mechanism (CCM) with chloroplast-expressed polyhydroxybutyrate (PHB) operon genes to produce renewable polyhydroxyalkanoate (PHA) plastics at commercially relevant levels in transgenic tobacco.
This research addresses the urgent need for renewable, bio-based plastics by engineering tobacco plants to produce polyhydroxyalkanoates (PHAs), a family of biodegradable polymers that can replace petroleum-derived plastics. The approach builds on prior work demonstrating that a cyanobacterial carbon concentrating mechanism (CCM) can boost photosynthesis in chloroplast transgenic tobacco. However, in wild-type backgrounds, CCM expression created sink-constrained plants with reduced photosynthetic efficiency. The proposed solution introduces an inducible chloroplast-expressed polyhydroxybutyrate operon (PhbA, PhbB, and PhbC) into CCM-expressing lines, creating a metabolic sink that converts excess carbon into commercially relevant quantities of PHB biopolymer.
This technology offers a sustainable pathway to produce high-quality renewable plastics directly in plant biomass, reducing dependence on fossil fuel-derived materials while leveraging enhanced photosynthetic carbon fixation.
This technology is at an early-to-mid stage of development. Prior validation has confirmed that CCM expression in Rubisco-depleted tobacco backgrounds increases photosynthesis and produces visibly larger plants. However, CCM expression in wild-type backgrounds revealed sink constraints characterized by elevated minimum fluorescence, compromised Photosystem II efficiency, and a pre-reduced plastoquinone pool. The next phase involves engineering CCM-expressing wild-type and Rubisco-depleted tobacco lines with the PHB operon genes, targeting them to the plastid or chloroplast genome to produce PHAs at commercially relevant concentrations. Transgenic lines will be characterized to quantify PHB production levels. Both chloroplast and nuclear transformation capabilities are established in the principal investigator's program, supporting ongoing development toward commercial-scale biopolymer production.
Texas A&M University in College Station is a comprehensive public research university and the flagship of The Texas A&M University System, combining broad academic strengths with a strong applied‑research culture. Industry collaborates on the Texas A&M‑RELLIS campus—an integrated education, research and testing environment that supports large‑scale experimentation and proving grounds—and through the Texas A&M Transportation Institute’s facilities in Bryan‑College Station. A statewide extension network connects university expertise to companies and communities across all Texas counties, enabling rapid piloting and deployment. Research is supported by competitive federal funding from agencies such as NSF, NIH, DOE, USDA and DoD, alongside state and industry sponsorship. Texas A&M Innovation provides IP management, licensing and commercialization pathways across the system.